Suppr超能文献

相似文献

1
Incidence and profile of C3 Glomerulopathy: A single center study.
Indian J Nephrol. 2015 Jan-Feb;25(1):8-11. doi: 10.4103/0971-4065.136889.
2
Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
Diagn Pathol. 2015 Mar 17;10:6. doi: 10.1186/s13000-015-0233-0.
3
Clinico-pathological Profile and Outcome of C-3 Glomerulopathy in Indian Children.
Indian J Nephrol. 2020 Nov-Dec;30(6):370-376. doi: 10.4103/ijn.IJN_226_18. Epub 2020 Feb 7.
4
Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.
Am J Kidney Dis. 2018 Jul;72(1):84-92. doi: 10.1053/j.ajkd.2017.11.019. Epub 2018 Feb 9.
6
C4 Glomerulopathy: A Disease Entity Associated With C4d Deposition.
Am J Kidney Dis. 2016 Jun;67(6):949-53. doi: 10.1053/j.ajkd.2016.01.012. Epub 2016 Feb 17.
7
C3 Glomerulopathy.
Pediatr Nephrol. 2017 Jan;32(1):43-57. doi: 10.1007/s00467-015-3310-4. Epub 2016 Apr 7.
8
C4d as a Diagnostic Tool in Proliferative GN.
J Am Soc Nephrol. 2015 Nov;26(11):2852-9. doi: 10.1681/ASN.2014040406. Epub 2015 May 19.
9
C3 glomerulopathy: A new complement-based entity.
Rev Clin Esp (Barc). 2014 Jun-Jul;214(5):266-74. doi: 10.1016/j.rce.2014.01.016. Epub 2014 Feb 24.
10
Toward a working definition of C3 glomerulopathy by immunofluorescence.
Kidney Int. 2014 Feb;85(2):450-6. doi: 10.1038/ki.2013.340. Epub 2013 Sep 25.

引用本文的文献

1
Role of Direct Immunofluorescence Microscopy in Spectrum of Diffuse Proliferative Glomerulonephritis: A Single-Center Study.
J Microsc Ultrastruct. 2021 Feb 9;9(4):177-182. doi: 10.4103/JMAU.JMAU_62_20. eCollection 2021 Oct-Dec.
2
Clinico-pathological Profile and Outcome of C-3 Glomerulopathy in Indian Children.
Indian J Nephrol. 2020 Nov-Dec;30(6):370-376. doi: 10.4103/ijn.IJN_226_18. Epub 2020 Feb 7.
4
Evaluation of cases of membranoproliferative glomerulonephritis according to newer classification: A retrospective record-based study.
Med J Armed Forces India. 2018 Jul;74(3):264-267. doi: 10.1016/j.mjafi.2017.01.008. Epub 2017 Feb 16.
5
C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction.
Case Rep Nephrol Dial. 2018 Feb 8;8(1):25-34. doi: 10.1159/000486848. eCollection 2018 Jan-Apr.

本文引用的文献

1
C3 glomerulopathy: clinicopathologic features and predictors of outcome.
Clin J Am Soc Nephrol. 2014 Jan;9(1):46-53. doi: 10.2215/CJN.04700513. Epub 2013 Oct 31.
2
C3 glomerulopathy: consensus report.
Kidney Int. 2013 Dec;84(6):1079-89. doi: 10.1038/ki.2013.377. Epub 2013 Oct 30.
3
Dense deposit disease and C3 glomerulopathy.
Semin Nephrol. 2013 Nov;33(6):493-507. doi: 10.1016/j.semnephrol.2013.08.002.
4
Toward a working definition of C3 glomerulopathy by immunofluorescence.
Kidney Int. 2014 Feb;85(2):450-6. doi: 10.1038/ki.2013.340. Epub 2013 Sep 25.
5
Recent insights into C3 glomerulopathy.
Nephrol Dial Transplant. 2013 Jul;28(7):1685-93. doi: 10.1093/ndt/gfs430. Epub 2013 Mar 10.
6
Alternative pathway dysfunction in kidney disease: a case report and review of dense deposit disease and C3 glomerulopathy.
Am J Kidney Dis. 2013 May;61(5):828-31. doi: 10.1053/j.ajkd.2012.11.045. Epub 2013 Feb 5.
7
Treatment options for C3 glomerulopathy.
Curr Opin Nephrol Hypertens. 2013 Mar;22(2):231-7. doi: 10.1097/MNH.0b013e32835da24c.
8
Pathogenesis of the C3 glomerulopathies and reclassification of MPGN.
Nat Rev Nephrol. 2012 Nov;8(11):634-42. doi: 10.1038/nrneph.2012.213. Epub 2012 Oct 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验